Cleared Traditional

K983842 - BIOTEST ANTI-EBV RECOMBINANT, EA IGM

K983842 is an FDA 510(k) clearance for BIOTEST ANTI-EBV RECOMBINANT, manufactured by Biotest Diagnostics Corp.. The device is a Class 1 Microbiology device with product code LSE cleared through the Traditional 510(k) pathway after a 222-day FDA review.

K983842 · Biotest Diagnostics Corp. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1999
Decision
222d
Days
Class 1
Risk

K983842 is an FDA 510(k) clearance for the BIOTEST ANTI-EBV RECOMBINANT, EA IGM. Classified as Epstein-barr Virus, Other (product code LSE), Class I - General Controls.

Submitted by Biotest Diagnostics Corp. (Denville, US). The FDA issued a Cleared decision on June 9, 1999 after a review of 222 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3235 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Biotest Diagnostics Corp. devices

FDA 510(k) Submission Details - K983842

510(k) Number K983842 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 30, 1998
Decision Date June 09, 1999
Days to Decision 222 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
120d slower than avg
Panel avg: 102d · This submission: 222d
Pathway characteristics
Predicate-based equivalence.

LSE Device Classification - Class 1, General Controls

Product Code LSE Epstein-barr Virus, Other
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3235
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LSE Epstein-barr Virus, Other

All 47
Devices cleared under the same product code (LSE) and FDA review panel - the closest regulatory comparables to K983842.
ETI-EA-G ASSAY
K992191 · DiaSorin, Inc. · Jul 1999
BIOTEST ANTI-EBV RECOMBINANT
K983839 · Biotest Diagnostics Corp. · Jun 1999
BIOTEST ANTI-EBV RECOMBINANT, EBNA IGG
K983841 · Biotest Diagnostics Corp. · Jun 1999
COPALIS MULTIPLEX EBV ANTIBODY ASSAY
K991660 · DiaSorin, Inc. · Jun 1999
EBV-VCA IGG ELISA TEST SYSTEM
K981812 · Diamedix Corp. · Mar 1999
THE APTUS (AUTOMATED) APPLICATION OF THE EBV-VCA IGM ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FO
K983801 · Zeus Scientific, Inc. · Dec 1998